> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Since Our Last Issue ...
- URL: https://www.fdaweb.com/since-our-last-issue-64/
- Published: 2022-02-27T12:00:00.000Z
- Updated: 2026-09-14T17:34:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139374

**Avara Pharmaceutical Services** has signed an agreement with **Pfizer** to acquire its Liscate, Italy sterile manufacturing facility. Avara Pharmaceutical Services is a contract manufacturing and technical services company providing both active pharmaceutical ingredient formulation and manufacturing, along with secondary formulation, manufacturing and packaging of small molecule drugs, including highly potent compounds.

New York-based private investment firm **SK Capital** has agreed to acquire **Perrigo API**, the active pharmaceutical ingredients business of Perrigo Co. in Israel for $110m in an all-cash deal. Under the terms of the transaction, the parties will enter into a long-term supply agreement for Perrigo API to supply its inventory of existing commercial and pipeline APIs to Perrigo.

**A&E Medical** has reached a deal with **RTI Surgical** to acquire its cardiothoracic closure business. RTI Surgical provides surgeons with biologic, metal, and synthetic implants that are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures.